U.S. stocks slipped on Tuesday after some disappointing consumer data. February retail sales fell 0.1 percent, matching economists’ forecasts. January’s previously reported 0.2 percent increase was revised downward to a 0.4 percent decline. Meanwhile, the Bank of Japan kept its benchmark interest rates unchanged and in negative territory. No additional stimulus measures were announced, but more may be on the way soon. ‘I could see them engaging in some additional quantitative easing down the road,’ said Steve Friedman, senior investment strategist at BNP Paribas Investment Partners. ‘I think it makes sense to wait for the time being – I don’t think they are in any particular rush.’ Meanwhile, shares of Valeant Pharmaceuticals (VRX) slumped after the drugmaker posted weak guidance. It expects first quarter earnings between $1.30 and $1.55 a share, compared to a previously reported $2.35 to $2.55. TheStreet’s Scott Gamm reports from Wall Street.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
